Xebio Holdings Co., Ltd. (TYO:8281)
1,275.00
-50.00 (-3.77%)
Apr 24, 2025, 3:30 PM JST
Xebio Holdings Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
Revenue | 248,545 | 242,433 | 239,293 | 223,282 | 202,438 | 225,312 | Upgrade
|
Revenue Growth (YoY) | 3.10% | 1.31% | 7.17% | 10.30% | -10.15% | -2.73% | Upgrade
|
Cost of Revenue | 152,381 | 149,546 | 147,519 | 136,228 | 123,618 | 136,585 | Upgrade
|
Gross Profit | 96,164 | 92,887 | 91,774 | 87,054 | 78,820 | 88,727 | Upgrade
|
Selling, General & Admin | 86,083 | 84,221 | 79,900 | 78,439 | 72,401 | 79,947 | Upgrade
|
Operating Expenses | 90,544 | 88,682 | 83,446 | 82,054 | 76,055 | 83,494 | Upgrade
|
Operating Income | 5,620 | 4,205 | 8,328 | 5,000 | 2,765 | 5,233 | Upgrade
|
Interest Expense | -125 | -104 | -64 | -120 | -124 | -26 | Upgrade
|
Interest & Investment Income | 102 | 98 | 87 | 59 | 54 | 61 | Upgrade
|
Currency Exchange Gain (Loss) | 785 | 555 | 323 | 559 | 150 | -27 | Upgrade
|
Other Non Operating Income (Expenses) | 592 | 650 | 566 | 2,353 | 1,496 | 601 | Upgrade
|
EBT Excluding Unusual Items | 6,974 | 5,404 | 9,240 | 7,851 | 4,341 | 5,842 | Upgrade
|
Gain (Loss) on Sale of Investments | -455 | 4 | - | -19 | 8 | 132 | Upgrade
|
Gain (Loss) on Sale of Assets | -6 | 2 | 5 | -13 | 1,380 | 101 | Upgrade
|
Asset Writedown | -861 | -724 | -777 | -1,583 | -2,847 | -3,115 | Upgrade
|
Other Unusual Items | -119 | -166 | 366 | -22 | 212 | 225 | Upgrade
|
Pretax Income | 5,533 | 4,520 | 8,834 | 6,214 | 3,094 | 3,185 | Upgrade
|
Income Tax Expense | 2,206 | 1,789 | 3,241 | 2,361 | 2,681 | 2,766 | Upgrade
|
Earnings From Continuing Operations | 3,327 | 2,731 | 5,593 | 3,853 | 413 | 419 | Upgrade
|
Minority Interest in Earnings | -56 | -139 | -196 | -17 | -1 | -11 | Upgrade
|
Net Income | 3,271 | 2,592 | 5,397 | 3,836 | 412 | 408 | Upgrade
|
Net Income to Common | 3,271 | 2,592 | 5,397 | 3,836 | 412 | 408 | Upgrade
|
Net Income Growth | -4.44% | -51.97% | 40.69% | 831.07% | 0.98% | -78.34% | Upgrade
|
Shares Outstanding (Basic) | 44 | 44 | 44 | 44 | 44 | 44 | Upgrade
|
Shares Outstanding (Diluted) | 44 | 44 | 44 | 44 | 44 | 44 | Upgrade
|
Shares Change (YoY) | -1.40% | 0.11% | 0.04% | 0.07% | 0.05% | -0.48% | Upgrade
|
EPS (Basic) | 75.11 | 58.63 | 122.07 | 86.77 | 9.32 | 9.23 | Upgrade
|
EPS (Diluted) | 74.65 | 58.31 | 121.58 | 86.44 | 9.29 | 9.20 | Upgrade
|
EPS Growth | -3.12% | -52.04% | 40.65% | 830.46% | 0.98% | -78.26% | Upgrade
|
Free Cash Flow | - | -51 | 3,663 | -1,286 | 22,973 | -5,829 | Upgrade
|
Free Cash Flow Per Share | - | -1.15 | 82.51 | -28.98 | 518.02 | -131.51 | Upgrade
|
Dividend Per Share | 15.000 | 30.000 | 30.000 | 30.000 | 30.000 | 32.500 | Upgrade
|
Dividend Growth | -50.00% | - | - | - | -7.69% | -7.14% | Upgrade
|
Gross Margin | 38.69% | 38.31% | 38.35% | 38.99% | 38.93% | 39.38% | Upgrade
|
Operating Margin | 2.26% | 1.73% | 3.48% | 2.24% | 1.37% | 2.32% | Upgrade
|
Profit Margin | 1.32% | 1.07% | 2.25% | 1.72% | 0.20% | 0.18% | Upgrade
|
Free Cash Flow Margin | - | -0.02% | 1.53% | -0.58% | 11.35% | -2.59% | Upgrade
|
EBITDA | 11,481 | 9,297 | 12,395 | 9,247 | 7,224 | 9,684 | Upgrade
|
EBITDA Margin | 4.62% | 3.84% | 5.18% | 4.14% | 3.57% | 4.30% | Upgrade
|
D&A For EBITDA | 5,861 | 5,092 | 4,067 | 4,247 | 4,459 | 4,451 | Upgrade
|
EBIT | 5,620 | 4,205 | 8,328 | 5,000 | 2,765 | 5,233 | Upgrade
|
EBIT Margin | 2.26% | 1.73% | 3.48% | 2.24% | 1.37% | 2.32% | Upgrade
|
Effective Tax Rate | 39.87% | 39.58% | 36.69% | 38.00% | 86.65% | 86.84% | Upgrade
|
Advertising Expenses | - | 7,401 | 6,372 | 6,194 | 5,001 | 5,663 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.